SCHEMBL9323102

SCHEMBL9323102

Fc1cc(F)cc(/C=N\C2C3CCN(CC3)C2C(c2ccccc2)c2ccccc2)c1

nearest known ligand 0.54

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TACR1 P25103 18/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9323089 1.00 TACR1 (0.54) TACR1
SCHEMBL9323097 1.00 TACR1 (0.54) TACR1
SCHEMBL9323107 1.00 TACR1 (0.54) TACR1
SCHEMBL9324123 0.91 TACR1 (0.52) TACR1
SCHEMBL9324107 0.91 TACR1 (0.52) TACR1
SCHEMBL9324111 0.91 TACR1 (0.52) TACR1
SCHEMBL9324115 0.91 TACR1 (0.52) TACR1
SCHEMBL9324137 0.89 TACR1 (0.52) TACR1
SCHEMBL9324119 0.89 TACR1 (0.52) TACR1
SCHEMBL9324143 0.89 TACR1 (0.52) TACR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0409931-B1 QUINUCLIDINE THERAPEUTIC AGENTS PFIZER (US) 1994-02-16 EP disclosed
US-5162339-A Substance P Antagonists, Gastrointestinal and Central Nervous System Disorders, Antiinflammatory Agents, Analgesics PFIZER INC. (US) 1992-11-10 US disclosed
WO-1990005525-A1 QUINUCLIDINE DERIVATIVES AS SUBSTANCE P ANTAGONISTS PFIZER INC. (US) 1990-05-31 WO disclosed